Downloaded by 80.82.77.83 on December 31, 2017 | http://pubs.acs.org Publication Date (Web): August 29, 2016 | doi: 10.1021/bk-2016-1220.ix002
Subject Index C
N
Chemical sciences, role in the National Nanotechnology Initiative, 23 acronyms, list, 34 creation, engines commercialization, renewed focus, 32 grand challenges, nanotechnologies, 33 National Nanotechnology Initiative about the NNI, 25 advanced materials, research, 28 cancerous tumors, detection, 30 Library of Congress, storage, 29 NNI membership and budgets, 26f NNI structure, 27f
Nanomaterials biomedical uses and applications, 89 first generation drug nanomedicines, 91 nanomedical drugs International Federation of Pharmaceutical Manufacturers & Associations, 90 nano-PEGylated enzyme, 90 nanomedicines, next generation, 91 14C-radiolabeled polymer nanoparticles, 92 nanomaterials, synthesis and manufacture, 92 safety considerations nanomaterials, rules for safety, 93 Nanotechnology, foundational knowledge and infrastructure foundational megatrend, 40 converging foundational technologies, 41f NNI, international government R&D funding, 41f two science and technology megatrends, S-curves, 42f general purpose technology, stages for establishing, 43 DOD NNI institutes, 48t five NNI user facilities, DOE network, 47t four NNI centers and networks, NIH network, 47t general purpose technology, creation, 44f main NSF R&D centers, 46t nanotechnology development, first stage (Nano 1), 45 nanotechnology development, second stage (Nano 2), 48 nanotechnology development, third decade (Nano 3), 50 NIST user facilities, 48t U.S. National Nanotechnology Initiative, priorities, 49 Nanotechnology, responsible development ethical conduct of research, responsible development, 112 responsible development corporate social responsibility, 115 emerging technologies, public engagement, 116
E Economic development, university roles SUNY facilities and programs, 69 DOD’s funding opportunity advancement, 70 SUNY public-private partnerships, 68 SUNY POLY sites, locations, 69f SUNY startups, 67 Emphasis on national security, nanomaterials and nanomanufacturing associated projects, 55 Nanomaterials Grand Challenge roadmap, 56f nanotechnology of interest to DoD, examples, 56t DoD research and engineering (R&E), 53 nanotechnology, future, 57
G Governance paradigms, 97 emerging technologies, management, 98 EPA’s Water Office, 100 human civilization, dystopian collapse, 98 nanoscale chemical substances, 99 nanotechnology, federal policy, 101 nanotechnology, regulation, 99 Office of Pesticide Programs (OPP), 100
127 Cheng et al.; Nanotechnology: Delivering on the Promise Volume 1 ACS Symposium Series; American Chemical Society: Washington, DC, 2016.
Downloaded by 80.82.77.83 on December 31, 2017 | http://pubs.acs.org Publication Date (Web): August 29, 2016 | doi: 10.1021/bk-2016-1220.ix002
European Commission’s Code of Conduct for Responsible Nanosciences and Nanotechnologies Research, 116 operational or institutional changes, 117 Responsible NanoCode, 116 social scientists, integration, 117 risk assessment, responsible development, 113 DuPont/Environmental Defense Nano Risk Framework, 114 nanomaterials, transparency in the use, 114 Nanotechnology workplace, adaptive governance proactive/anticipatory risk mitigation challenges, proactive risk mitigation, 104 coordination, 107 mitigate exposures, prudent measures, 105 nanotechnology, risk management, 104 public-private partnerships, 106 qualitative anticipatory risk mitigation tools, 105 soft and hard law approaches, integration, 105 National Institutes of Health, 59 background and history, 60 comments, 62 active clinical research, selected number of areas, 65t nanoengineering, sampling of technology, 64t NT-enabled devices, examples, 63t nanotechnology, NIH research programs NCI Alliance for Nanotechnology in Cancer, 61 NHLBI Programs of Excellence in Nanotechnology (PENs), 61 NIH Common Fund Nanomedicine Initiative, 61 Northwestern University, nanotechnology, 15 International Institute for Nanotechnology, 16 medicine, convergence of nanoscience and nanotechnology, 17 Small Business Evaluation and Entrepreneur’s (SBEE) Program, 16 spherical nucleic acids (SNAs), 17 spherical nucleic acids, commercial forms and uses, 19 structure of a SNA, schematic, 18f
O Overview, nanotechnology, 1 challenges, 7 planning and managing nanotechnology, 3 promising outcomes bio/medicine, opportunities, 6 energy and electronics, opportunities, 4 food and agriculture, opportunities, 7 materials, opportunities, 5
R Regulations, 75 DuPont-Environmental Defense Fund, 77 familiar and new elements, 78 flexible and practical, 78 nano risk framework, 79f six-step process, nano risk framework, 78 step 1, 78 step 2, 78 step 3, 79 step 4, 79 step 5, 79 step 6, 79 industry product stewardship commitment, 77 OECD WPMN, 80 Organisation for Economic Co-Operation and Development (OECD), 81 sponsorship testing program, 81 Working Party On Manufactured Nanomaterials (WPMN), 81 risk-based regulatory principles, 82
S Sustainability and life-cycle regulatory decision making, 85 life-cycle assessment models, 86 life cycle thinking, 86 Toxic Substance Control Act (TSCA), 86 reporting rule, 87
128 Cheng et al.; Nanotechnology: Delivering on the Promise Volume 1 ACS Symposium Series; American Chemical Society: Washington, DC, 2016.
